vs
Side-by-side financial comparison of Emerald Holding, Inc. (EEX) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $132.7M, roughly 1.2× Emerald Holding, Inc.). Emerald Holding, Inc. runs the higher net margin — -22.8% vs -82.0%, a 59.2% gap on every dollar of revenue. On growth, Emerald Holding, Inc. posted the faster year-over-year revenue change (24.3% vs -22.7%). Emerald Holding, Inc. produced more free cash flow last quarter ($11.7M vs $-36.6M). Over the past eight quarters, Emerald Holding, Inc.'s revenue compounded faster (-0.3% CAGR vs -11.5%).
TVS Emerald Haven Realty Limited is an Indian real estate development company headquartered in Chennai, Tamil Nadu. A subsidiary of TVS Holdings, it specializes in sustainable residential communities and urban development projects.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
EEX vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $132.7M | $164.7M |
| Net Profit | $-30.2M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | -11.8% | -43.3% |
| Net Margin | -22.8% | -82.0% |
| Revenue YoY | 24.3% | -22.7% |
| Net Profit YoY | -692.2% | -104.8% |
| EPS (diluted) | $-0.15 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $132.7M | $164.7M | ||
| Q3 25 | $77.5M | $211.0M | ||
| Q2 25 | $105.5M | $178.9M | ||
| Q1 25 | $147.7M | $1.2B | ||
| Q4 24 | $106.8M | $213.2M | ||
| Q3 24 | $72.6M | $196.8M | ||
| Q2 24 | $86.0M | $186.7M | ||
| Q1 24 | $133.4M | $210.1M |
| Q4 25 | $-30.2M | $-135.0M | ||
| Q3 25 | $-14.4M | $15.9M | ||
| Q2 25 | $-1.4M | $-64.8M | ||
| Q1 25 | $15.3M | $866.6M | ||
| Q4 24 | $5.1M | $-65.9M | ||
| Q3 24 | $-11.1M | $-106.7M | ||
| Q2 24 | $-2.8M | $-99.2M | ||
| Q1 24 | $11.0M | $-91.6M |
| Q4 25 | -11.8% | -43.3% | ||
| Q3 25 | -10.1% | 1.4% | ||
| Q2 25 | 9.7% | -19.5% | ||
| Q1 25 | 24.2% | 82.5% | ||
| Q4 24 | 19.5% | -76.2% | ||
| Q3 24 | -6.5% | -27.7% | ||
| Q2 24 | 7.4% | -21.5% | ||
| Q1 24 | 18.2% | -21.6% |
| Q4 25 | -22.8% | -82.0% | ||
| Q3 25 | -18.6% | 7.5% | ||
| Q2 25 | -1.3% | -36.3% | ||
| Q1 25 | 10.4% | 73.7% | ||
| Q4 24 | 4.8% | -30.9% | ||
| Q3 24 | -15.3% | -54.2% | ||
| Q2 24 | -3.3% | -53.1% | ||
| Q1 24 | 8.2% | -43.6% |
| Q4 25 | $-0.15 | $-1.63 | ||
| Q3 25 | $-0.07 | $0.20 | ||
| Q2 25 | $-0.01 | $-0.83 | ||
| Q1 25 | $0.08 | $10.04 | ||
| Q4 24 | $0.01 | $-0.85 | ||
| Q3 24 | $-0.05 | $-1.39 | ||
| Q2 24 | $-0.03 | $-1.29 | ||
| Q1 24 | $0.00 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $100.9M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $338.8M | $-205.3M |
| Total Assets | $1.2B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $100.9M | $1.9B | ||
| Q3 25 | $95.4M | $1.7B | ||
| Q2 25 | $156.4M | $2.0B | ||
| Q1 25 | $276.8M | $2.0B | ||
| Q4 24 | $194.8M | $1.1B | ||
| Q3 24 | $188.9M | $1.0B | ||
| Q2 24 | $193.2M | $1.1B | ||
| Q1 24 | $186.8M | $884.8M |
| Q4 25 | $338.8M | $-205.3M | ||
| Q3 25 | $369.5M | $-155.8M | ||
| Q2 25 | $389.4M | $-206.5M | ||
| Q1 25 | $392.1M | $-185.8M | ||
| Q4 24 | $385.9M | $-1.1B | ||
| Q3 24 | $391.1M | $-1.1B | ||
| Q2 24 | $407.6M | $-980.2M | ||
| Q1 24 | $-90.7M | $-893.9M |
| Q4 25 | $1.2B | $2.9B | ||
| Q3 25 | $1.2B | $2.6B | ||
| Q2 25 | $1.2B | $2.6B | ||
| Q1 25 | $1.2B | $2.7B | ||
| Q4 24 | $1.0B | $1.7B | ||
| Q3 24 | $1.1B | $1.8B | ||
| Q2 24 | $1.1B | $1.9B | ||
| Q1 24 | $1.1B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | $-34.3M |
| Free Cash FlowOCF − Capex | $11.7M | $-36.6M |
| FCF MarginFCF / Revenue | 8.8% | -22.3% |
| Capex IntensityCapex / Revenue | 0.5% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.4M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | $-34.3M | ||
| Q3 25 | $1.8M | $-66.3M | ||
| Q2 25 | $15.9M | $-58.3M | ||
| Q1 25 | $12.6M | $870.1M | ||
| Q4 24 | $20.6M | $-30.0M | ||
| Q3 24 | $9.1M | $-77.0M | ||
| Q2 24 | $9.8M | $-71.5M | ||
| Q1 24 | $7.3M | $70.8M |
| Q4 25 | $11.7M | $-36.6M | ||
| Q3 25 | $1.5M | $-69.7M | ||
| Q2 25 | $15.8M | $-59.6M | ||
| Q1 25 | $12.4M | $868.4M | ||
| Q4 24 | $19.9M | $-33.8M | ||
| Q3 24 | $9.0M | $-77.5M | ||
| Q2 24 | $9.6M | $-78.8M | ||
| Q1 24 | $7.0M | $61.2M |
| Q4 25 | 8.8% | -22.3% | ||
| Q3 25 | 1.9% | -33.1% | ||
| Q2 25 | 15.0% | -33.3% | ||
| Q1 25 | 8.4% | 73.8% | ||
| Q4 24 | 18.6% | -15.8% | ||
| Q3 24 | 12.4% | -39.4% | ||
| Q2 24 | 11.2% | -42.2% | ||
| Q1 24 | 5.2% | 29.1% |
| Q4 25 | 0.5% | 1.4% | ||
| Q3 25 | 0.4% | 1.6% | ||
| Q2 25 | 0.1% | 0.7% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.7% | 1.8% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 0.2% | 4.0% | ||
| Q1 24 | 0.2% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.82× | 1.00× | ||
| Q4 24 | 4.04× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EEX
| Connections Segment | $121.9M | 92% |
| Commerce Segment | $5.5M | 4% |
| Content | $5.3M | 4% |
PTCT
Segment breakdown not available.
